The Blood Culture Tests Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Blood Culture Tests Market:
https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report
According to The Business Research Company’s Blood Culture Tests Global Market Report 2024, The blood culture tests market size has grown rapidly in recent years. It will grow from $6.22 billion in 2023 to $6.97 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increase in prevalence of infectious diseases, aging population, advances in healthcare infrastructure, rise in research and development.
The blood culture tests market size is expected to see rapid growth in the next few years. It will grow to $11.46 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to rising hospital-acquired infections, growing demand for point-of-care (poc) testing, increased healthcare spending, regulatory approvals. Major trends in the forecast period include telemedicine and remote testing, automation and ai, multiplex testing, sepsis management, infectious disease surveillance.
The increase in incidence of infectious diseases is expected to propel the growth of the blood culture test market. Infectious diseases are illnesses caused by pathogens, including viruses, bacteria, fungi, and parasites. These diseases have dangerous microorganisms or pathogens that enter an individual's body from the outside or from an infected person. These infectious diseases, such as COVID-19, tuberculosis, flu, measles, HIV, strep throat, and so on, have the potential to cause momentary pain, significant tissue damage, or even death. The World Health Organization ranks infectious diseases as the second biggest cause of death globally. These increases in the incidence of infectious diseases have led to an increase in the demand for blood culture tests to assist in determining whether a patient has bacteremia/septicemia, a potentially fatal condition, or not. For instance, in 2022, the World Health Organization, stated that approximately 6.4 million people died from COVID-19. Furthermore, due to tuberculosis (TB), a total of 1.5 million people died in 2020 worldwide. Therefore, the increasing incidence of infectious diseases is driving the growth of the blood culture test market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=7763&type=smp
The blood culture tests market covered in this report is segmented –
1) By Method: Conventional/Manual Methods, Automated Methods
2) By Product: Consumables, Instruments, Software and Services
3) By Technology: Culture-Based Technology, Molecular Technologies, Microarrays, PCR (Polymerase Chain Reaction), PNA-FiSH (Peptide Nucleic Acid – Fluroscent in Situ Hybridization), Proteomics Technology
4) By Application: Bacteremia, Fungemia, Mycobacterial Detection
5) By End User: Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories
The technological innovation is a key trend gaining popularity in the blood culture tests market. Innovation and globalization are creating new prospects for the pharmaceutical, biologics, nutraceuticals, and medical device industries. The desire to bring new products to market safely, quickly, and affordably necessitates producers and manufacturers to build world-class blood culture testing to demonstrate compliance with ever-expanding requirements. These technological innovations reduce costs through accurate and independent safety and performance assurance. For instance, In May 2022, Labcorp, a US-based testing laboratories company, launched Labcorp OnDemandTM at-home collection kit that measures hemoglobin A1c (HbA1c) from a small blood sample. This OnDemand Diabetes test kit employs dried blood technology to provide an overview of the body's average blood sugar levels over time. Through this kit, users can monitor their health status regularly from the comfort of their homes with a prick of the finger and a few drops of blood.
The blood culture tests market report table of contents includes:
1. Executive Summary
2. Blood Culture Tests Market Characteristics
3. Blood Culture Tests Market Trends And Strategies
4. Blood Culture Tests Market - Macro Economic Scenario
5. Global Blood Culture Tests Market Size and Growth
...............
31. Global Blood Culture Tests Market Competitive Benchmarking
32. Global Blood Culture Tests Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Blood Culture Tests Market
34. Blood Culture Tests Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email:
[email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model